Intellia Therapeutics Ownership & Insider Activity

Intellia Therapeutics (NTLA) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 2.8% of shares outstanding. Institutional investors hold 67.6%. Over the past 90 days, insiders made 3 sales worth $401K.

Shares Outstanding

140.127M

Shares Float

111.235M

Insider Shares Owned

3.896M

Insider % Owned

2.8%

Institutional Shares Held

94.736M

Institutional % Held

67.6%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$401K total

Net Activity

Net Selling

Net Value (90d)

-$401K

Intellia Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Oct 2, 2026	Michael Dube	VP, CHIEF ACCOUNTING OFFICER	SELL	1.864K	$12.43	$23K
Aug 20, 2026	JOHN LEONARD	PRESIDENT AND CEO	SELL	22.675K	$12.65	$287K
Jul 22, 2026	Edward Dulac III	EVP, CHIEF FINANCIAL OFFICER	SELL	8.111K	$11.25	$91K
Jul 2, 2026	Edward Dulac III	EVP, CHIEF FINANCIAL OFFICER	SELL	4.677K	$18.00	$84K
Jul 1, 2026	Michael Dube	VP, CHIEF ACCOUNTING OFFICER	SELL	2.641K	$16.78	$44K

Date	Member	Party	Chamber	Action	Amount
Aug 25, 2023	Thomas R. Carper	D	Senate	Sale	$1,001 - $15,000